A Study of Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and Older

Clinical trial NCT05327816 · TERMINATED

Trial details

NCT number: NCT05327816
Sponsor: Janssen Vaccines & Prevention B.V.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention

Start date: 2022-04-13
Primary completion: 2023-01-16
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.